Illinois Governor J.B. Pritzker says a weekly GLP-1 shot helped him drop 80 pounds and get off insulin, and he insists it is about health, not 2028.
Story Snapshot
- Pritzker says he has used a GLP-1 medication for two years and lost 80 pounds.
- He links the treatment to a Type 2 diabetes diagnosis and says it changed his health.
- He denies the weight loss is tied to a presidential run; he frames it as medical.
- His office says diet and exercise, plus the drug, helped him stop insulin use.
Pritzker Puts His Health Journey On The Record
Governor J.B. Pritzker told CBS Mornings he has been taking a GLP-1 medication every week for about two years. He said the therapy, alongside diet and exercise, led to an 80-pound weight loss and a major shift in how he feels.
He described the change as “really life changing.” The interview aired September 21, 2026, and set off instant national coverage because it tied a personal health story to a figure already in the 2028 conversation.
Pritzker said doctors diagnosed him with Type 2 diabetes two years ago and warned he would likely need insulin. He said he started the GLP-1 after that warning, and he now feels “a whole lot better.”
Multiple outlets recapped the interview and the details he shared. He did not name the specific drug or dose, but the core facts are his own words on camera and have been consistent across coverage.
Medical Framing First, Politics Second
Pritzker pushed back on the idea that the timing or the results were part of a presidential plan. He said he made the change for his health and his family, not for a campaign. The focus stayed on diabetes, energy, and day-to-day life.
That framing matters because GLP-1 drugs now sit in a hot zone where medicine, status, and politics overlap. Users face praise for results and heat over cost and access at the same time.
Politico reported the governor’s office said that with the medication, diet, and exercise, Pritzker is no longer on insulin and is down to levels that do not show diabetes or even prediabetes.
That claim tracks with how these drugs often work for people with Type 2 diabetes under a doctor’s care. The office did not release lab values, but the statement explains why he credits the treatment as more than weight loss.
What GLP-1 Therapy Typically Does And Why It Draws Fire
GLP-1 medications slow digestion, mute hunger, and improve insulin response. Doctors use them to manage diabetes and, in many cases, to reduce weight. Demand is high because results can be strong.
Debate is hot because prices are high, supply has been tight, and insurance coverage is spotty. Research and reviews say those access gaps fall hardest on people with less money or weaker insurance, which is why the politics of coverage never sits far from the science.
Social research shows another tension: many people still view GLP-1 use as an “easy way out.” That label fuels stigma for people who try to manage weight with medicine. Studies also link cost and side effects to low uptake and early drop-off.
These barriers set the stage for backlash when a wealthy public figure talks about success on the drugs, even when the purpose is diabetes control and not just a smaller waist.
Why This Disclosure Will Keep Echoing
Public figures often shape what voters think counts as normal health care. When a sitting governor explains a weekly injection and explains why he takes it, he helps move GLP-1 drugs from whispers to routine talk. That can reduce shame for people who might benefit.
It can also fuel fights over who pays, who qualifies, and whether leaders should speak to coverage rules if they also use the drugs themselves. Those fights are not going away.
Illinois Gov. JB Pritzker discloses diabetes diagnosis, 80-pound weight loss on GLP-1 drug https://t.co/GkdAL0okbu
— Chicago Breaking News (@ChicagoBreaking) September 22, 2026
The straight facts land cleanly. Pritzker says he was diagnosed with Type 2 diabetes, started a GLP-1 on medical advice, lost 80 pounds, and feels better. He denies a campaign angle. His office says he is off insulin now, with improved levels.
Voters will hear both the health story and the political hum around it. Common sense says judge the claims by the outcome he states and the consistency across outlets, and by whether policy choices serve the broad public, not one person.
Sources:
cbsnews.com, axios.com, chicagotribune.com, newser.com, pmc.ncbi.nlm.nih.gov, jmir.org
